(Q81481051)

English

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

scientific article published on 01 March 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

severe acute respiratory syndrome

1 reference

based on heuristic

inferred from title

7

object named as

Shibo Jiang

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Yuxian He

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Qingyu Zhu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shuwen Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yusen Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Baoan Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jiaming Li

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

334

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

74-82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

The secret life of ACE2 as a receptor for the SARS virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Infectious diseases. One year after outbreak, SARS virus yields some secrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Cellular entry of the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

SARS coronavirus: a new challenge for prevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

The Genome sequence of the SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Medicine. Caution urged on SARS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

The Use of Corticosteroids in SARS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

A model of the ACE2 structure and function as a SARS-CoV receptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Expression cloning of functional receptor used by SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

1 reference

https://pubmed.ncbi.nlm.nih.gov/15749124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/15749124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2005.01.034

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15749124%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81481051&oldid=1608355326"